Women were less than half of the people tested for almost all of these common medicines.

NCT04434664

BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

See it on ClinicalTrials.gov ↗

50 people

34 womenmiddle line = equal numbers16 men
Phase
PHASE4
Paid for by
University of Pennsylvania
Finished
2024-12-20
Health conditions
Heart Failure With Preserved Ejection Fraction, Hypertension
Who could join
Anyone
Ages
18 Years – 90 Years
Average age
mean 72 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Black / African American 66% · White 34% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%

Women left out

  • No pregnant women

    Women who were pregnant could not join.

    “Children, fetuses, neonates, prisoners, and pregnant women (women of childbearing age will undergo a pregnancy test during the screening visit) are not included in this research study.”

Study titles and rules are shown in their original English.